Growing concerns have emerged regarding the potential risks of gastroparesis associated with the use of GLP-1 receptor agonists such as Ozempic and Wegovy, commonly prescribed for obesity and diabetes management
Evidence-Based Tapering Schedules and Discontinuation Timelines There is no universal weaning protocoltapering depends on which GLP-1 medication you are taking, dose strength, treatment duration, and your individual health status
One Health 9 , 100123 (2020)
There is no single right answer here, and this is general information rather than personal advice, but broadly: Berberine may appeal to someone who wants gentle, natural support for blood sugar or general metabolic health, does not have a medical condition that requires prescription treatment, is not on interacting medications, and has realistic expectations about modest effects
According to the UCL study, four out of every five people taking a GLP-1 medicine for weight loss in the UK were on tirzepatide
hypoglycemia can occur if too much insulin is given